upstaza
ptc therapeutics international limited - eladocagene exuparvovec - aminosyre-metabolisme, infiserte feil - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.
adalat oros 20 mg
orifarm as - nifedipin - depottablett - 20 mg
adalat oros 30 mg
orifarm as - nifedipin - depottablett - 30 mg
adalat oros 30 mg
farmagon - nifedipin - depottablett - 30 mg
adalat oros 30 mg
farmagon - nifedipin - depottablett - 30 mg
adalat oros 30 mg
orifarm as - nifedipin - depottablett - 30 mg
adalat oros 30 mg
farmagon - nifedipin - depottablett - 30 mg